Detalles de la búsqueda
1.
Safety and efficacy of Sofosbuvir and Velpatasvir in children with active hepatitis C virus infection undergoing haploidentical transplantation.
Transpl Infect Dis
; 23(2): e13490, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33037697
2.
CTLA4Ig in an Extended Schedule along with Sirolimus Improves Outcome with a Distinct Pattern of Immune Reconstitution Following Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation for Hemoglobinopathies.
Biol Blood Marrow Transplant
; 26(8): 1469-1476, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32428732
3.
Impact of extended infusional mesna prophylaxis on the incidence of BK viruria and hemorrhagic cystitis following post-transplantation cyclophosphamide and CTLA4Ig-based haploidentical transplantation.
Ann Hematol
; 99(4): 839-845, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32025839
4.
Prophylactic oseltamivir during major seasonal influenza H1N1 outbreak might reduce both H1N1 and associated pulmonary aspergillosis in children undergoing haploidentical transplantation.
Transpl Infect Dis
; 22(5): e13309, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32383345
5.
CTLA4Ig Primed Donor Lymphocyte Infusion: A Novel Approach to Immunotherapy after Haploidentical Transplantation for Advanced Leukemia.
Biol Blood Marrow Transplant
; 25(4): 673-682, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30610925
6.
Impact of Preemptive Granulocyte Infusions During Febrile Neutropenia in Patients Colonized with Carbapenem-Resistant Gram-Negative Bacteria Undergoing Haploidentical Transplantation.
Biol Blood Marrow Transplant
; 25(8): 1621-1628, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31048086
7.
Rotavirus infection following post-transplantation cyclophosphamide based haploidentical hematopoietic cell transplantation in children is associated with hemophagocytic syndrome and high mortality.
Transpl Infect Dis
; 21(5): e13136, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31251433
8.
Higher CD45RA+ Regulatory T Cells in the Graft Improves Outcome in Younger Patients Undergoing T Cell-Replete Haploidentical Transplantation: Where Donor Age Matters.
Biol Blood Marrow Transplant
; 24(10): 2025-2033, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29906568
9.
Impact of Single-Dose Plerixafor as an Adjunct to Granulocyte Colony-Stimulating Factor-Based Peripheral Blood Stem Cell Mobilization on the Graft Composition and Outcome for T Cell-Replete Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: A Comparative Study.
Biol Blood Marrow Transplant
; 24(3): 542-548, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29191663
10.
CD56-enriched donor cell infusion after post-transplantation cyclophosphamide for haploidentical transplantation of advanced myeloid malignancies is associated with prompt reconstitution of mature natural killer cells and regulatory T cells with reduced incidence of acute graft versus host disease: A pilot study.
Cytotherapy
; 19(4): 531-542, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28131632
11.
Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Children with Advanced Acute Leukemia with Fludarabine-, Busulfan-, and Melphalan-Based Conditioning.
Biol Blood Marrow Transplant
; 22(3): 499-504, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26612281
12.
Improved Outcome of Refractory/Relapsed Acute Myeloid Leukemia after Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation with Myeloablative Conditioning and Early Prophylactic Granulocyte Colony-Stimulating Factor-Mobilized Donor Lymphocyte Infusions.
Biol Blood Marrow Transplant
; 22(10): 1867-1873, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27470289
13.
Haploidentical transplantation in children with unmanipulated peripheral blood stem cell graft: The need to look beyond post-transplantation cyclophosphamide in younger children.
Pediatr Transplant
; 20(5): 675-82, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27217372
14.
CTLA4Ig Limits Both Incidence and Severity of Early Cytokine Release Syndrome following Haploidentical Peripheral Blood Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 26(4): e86-e87, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31911258
15.
Long-Term Follow-Up of Abatacept, Post-Transplantation Cyclophosphamide, and Sirolimus-Based Haploidentical Transplantation in Younger Patients with Nonmalignant Diseases.
Transplant Cell Ther
; 30(6): 605.e1-605.e13, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38490295
16.
Augmenting Vaccine Efficacy against Delta Variant with 'Mycobacterium-w'-Mediated Modulation of NK-ADCC and TLR-MYD88 Pathways.
Vaccines (Basel)
; 11(2)2023 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36851206
17.
Impact of adaptive natural killer cells, KLRC2 genotype and cytomegalovirus reactivation on late mortality in patients with severe COVID-19 lung disease.
Clin Transl Immunology
; 11(1): e1359, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35035954
18.
Impact of an Immune Modulator Mycobacterium-w on Adaptive Natural Killer Cells and Protection Against COVID-19.
Front Immunol
; 13: 887230, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35603154
19.
Early and Sustained Expansion of Adaptive Natural Killer Cells Following Haploidentical Transplantation and CTLA4Ig-Primed Donor Lymphocyte Infusions Dissociate Graft-versus-Leukemia and Graft-versus-Host Effects.
Transplant Cell Ther
; 27(2): 144-151, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33830023
20.
CTLA4Ig-primed donor lymphocyte infusions following haploidentical transplantation improve outcome with a distinct pattern of early immune reconstitution as compared to conventional donor lymphocyte infusions in advanced hematological malignancies.
Bone Marrow Transplant
; 56(1): 185-194, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32704091